Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jan. 29, 2023	Jan. 30, 2022
Cash flows from operating activities:
Net income	$ 28,950	$ 31,726
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	19,105	20,810
Share-based compensation	1,821	1,457
Changes in assets and liabilities:
Accounts receivable	(7,565)	3,269
Inventories	1,705	(7,020)
Other current assets	(13,060)	(6,730)
Accounts payable, accrued liabilities, and other	(3,276)	15,618
Net cash provided by operating activities	27,680	59,130
Cash flows from investing activities:
Purchases of property, plant and equipment	(31,097)	(19,175)
Government incentives	1,014	0
Other	(87)	(43)
Net cash used in investing activities	(30,170)	(19,218)
Cash flows from financing activities:
Repayments of debt	(9,218)	(15,192)
Purchases of treasury stock	0	(2,522)
Contribution from noncontrolling interest	0	14,997
Proceeds from share-based arrangements	672	3,840
Net settlements of restricted stock awards	(1,168)	(1,458)
Net cash used in financing activities	(9,714)	(335)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	27,499	(2,057)
Net increase in cash, cash equivalents, and restricted cash	15,295	37,520
Cash, cash equivalents, and restricted cash at beginning of period	322,409	279,680
Cash, cash equivalents, and restricted cash at end of period	337,704	317,200
Less: Ending restricted cash	2,912	3,005
Cash and cash equivalents at end of period	334,792	314,195
Supplemental disclosure of non-cash information:
Accruals for property, plant and equipment purchased during year	$ 12,031	$ 7,092